S. Santamarina-fojo et al., Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis, CURR OP LIP, 11(3), 2000, pp. 267-275
In the past several years significant advances have been made in our unders
tanding of lecithin-cholesterol acyltransferase (LCAT) function. LCAT benef
icially alters the plasma concentrations of apolipoprotein B-containing lip
oproteins, as well as HDL. In addition, its proposed role in facilitating r
everse cholesterol transport and modulating atherosclerosis has been demons
trated in vivo. Analysis of LCAT transgenic animals has established the imp
ortance of evaluating HDL function, as well as HDL plasma levels, to predic
t atherogenic risk. Curr Opin Lipidol 11:267-275. (C) 1000 Lippincott Willi
ams & Wilkins.